Real-World Characteristics and Treatment Patterns of Patients Treated with Talazoparib + Enzalutamide for Metastatic Castration- Resistant Prostate Cancer in the US Community Oncology Setting First published 04/08/2026 Last updated 04/08/2026 EU PAS number:EUPAS1000000931 Study Planned